GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (OTCPK:CPHI) » Definitions » Shiller PE Ratio
中文

China Pharma Holding (China Pharma Holding) Shiller PE Ratio : (As of Apr. 25, 2024)


View and export this data going back to 2002. Start your Free Trial

What is China Pharma Holding Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


China Pharma Holding Shiller PE Ratio Historical Data

The historical data trend for China Pharma Holding's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Shiller PE Ratio Chart

China Pharma Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

China Pharma Holding Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of China Pharma Holding's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Pharma Holding's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's Shiller PE Ratio falls into.



China Pharma Holding Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

China Pharma Holding's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, China Pharma Holding's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.116/114.6694*114.6694
=-0.116

Current CPI (Dec. 2023) = 114.6694.

China Pharma Holding Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -2.500 98.600 -2.907
201406 -10.000 98.200 -11.677
201409 -7.500 98.900 -8.696
201412 -25.500 99.000 -29.536
201503 -4.500 99.900 -5.165
201506 1.500 99.500 1.729
201509 3.500 100.500 3.993
201512 -7.000 100.600 -7.979
201603 -2.000 102.200 -2.244
201606 -3.000 101.400 -3.393
201609 -2.000 102.400 -2.240
201612 -4.000 102.600 -4.471
201703 -1.000 103.200 -1.111
201706 -2.500 103.100 -2.781
201709 -2.500 104.100 -2.754
201712 -15.500 104.500 -17.008
201803 -0.500 105.300 -0.544
201806 -1.000 104.900 -1.093
201809 -2.000 106.600 -2.151
201812 -9.000 106.500 -9.690
201903 -0.500 107.700 -0.532
201906 -1.000 107.700 -1.065
201909 -1.000 109.800 -1.044
201912 -22.000 111.200 -22.686
202003 -1.000 112.300 -1.021
202006 0.015 110.400 0.016
202009 -1.000 111.700 -1.027
202012 -1.500 111.500 -1.543
202103 -1.000 112.662 -1.018
202106 -1.000 111.769 -1.026
202109 -1.000 112.215 -1.022
202112 -1.200 113.108 -1.217
202203 -1.100 114.335 -1.103
202206 -0.900 114.558 -0.901
202209 -0.800 115.339 -0.795
202212 -0.980 115.116 -0.976
202303 -0.300 115.116 -0.299
202306 -0.300 114.558 -0.300
202309 -0.300 115.339 -0.298
202312 -0.116 114.669 -0.116

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China Pharma Holding  (OTCPK:CPHI) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


China Pharma Holding Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Pharma Holding (China Pharma Holding) Business Description

Traded in Other Exchanges
N/A
Address
Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Executives
Ke Deng 10 percent owner NO.17, JINPAN ROAD, SECOND FLOOR, HAIKOU F4 570216
Frank Waung officer: Chief Financial Officer 72 GREAT HILLS RD., SHORT HILLS NJ 07078
G Michael Bennett director 4/F, NO. 3 JINYUAN ROAD, DAXING DISTRICT INDUSTRIAL DEVELOPMENT A, BEIJING F4 102600
Yingwen Zhang director NO. 5, UNIT 1, BLDG. 4, NO. 14 XIN NAN ZHI RD., CHENGDU, SICHUAN F4 610041
Baowen Dong director NO.9, BLDG. 9, SOUTH PARK, NO. 24, SECTION 1, 1ST RING ROAD, CHENGDU, SICHUAN F4 610041
Heung Mei Tsui director, 10 percent owner FLAT F, 3RD FL., MAYSON GARDEN BLDG., 68 HING FAT ST., CAUSEWAY BAY, HONG KONG F4 XXXXX
Zhilin Li officer: President and CEO 2/F JIAHAI BLDG., NO. 17 JINPAN ROAD, JINPAN INDUSTRY DEVELOPMENT, HAIKOU, HAINAN PROVINCE F4 570216
Jian Yang officer: Secretary NO. 1 HAOYUAN ROAD, XINHUA DISTRICT, HAIKOU, HAINAN PROVI F4 570216
Xinhua Wu officer: CFO 2/F JIAHAI BLDG., NO. 17 JINPAN ROAD, JINPAN INDUSTRY DEVELOPMENT, HAIKOU, HAINAN PROVI F4 570216
George L Diamond 10 percent owner 174 FM 1830, ARGYLE TX 76226
David F Brigante 10 percent owner 174FM 1830, ARGYLE TX 76226
Marat Rosenberg 10 percent owner 17 FM 1830, ARGYLE TX 76226
Halter Financial Investments Lp 10 percent owner 174 FM 1830, ARGYLE TX 76226
Halter Financial Investments Gp Llc 10 percent owner 174 FM 1830, ARGYLE TX 76226
Timothy P Halter director, 10 percent owner, officer: CEO, President & CFO 174 FM 1830, ARGYLE TX 76226